| Execution period | 60 months |
|---|
NSE filing, NSE: AAKAAR. Summary written from the filing by ALFA Finder's alert engine.
Aakaar Medical Technologies Ltd: key numbers
- Share price
- ₹71.00
- Market cap
- ₹100.6 Cr
- Revenue (annual)
- ₹66.96 Cr
- Net profit (annual)
- ₹6.64 Cr
- P/E (TTM)
- 15.2×Sector 52.0×
- Promoter holding
- 67.05%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aakaar Medical Technologies Ltd
All →Aakaar Medical Technologies Board Meeting Date
Aakaar Medical Technologies Limited will hold a board meeting on 30-Oct-2026 to consider unaudited half-yearly financial results and ESOP matters.
Aakaar Medical Technologies Other Announcement
Aakaar Medical Technologies Limited submitted its Reconciliation of Share Capital Audit Report for the quarter ended September 30, 2026. The report confirms total issued capital remains at 1,41,72,816 equity shares.
Aakaar Medical Technologies Business Update
Aakaar Medical Technologies provided an operational update for Q1 FY2026-27, detailing expansion in its clinic network, distributor count, and overall sales force effectiveness.
Aakaar Medical Technologies Legal & Regulatory
Aakaar Medical Technologies addressed an NSE notice regarding Regulation 44(3) non-compliance, stating the lapse was inadvertent and that corrective measures have been implemented.
Aakaar Medical Technologies Legal & Regulatory
Aakaar Medical Technologies submitted a share‑capital audit reconciliation reporting issued capital of ₹14.17 Crore. The filing satisfies SEBI (Depositories and Participants) Regulation 76 requirements.
- Value
- ₹14.17 Cr
Aakaar Medical Technologies Annual General Meeting
Aakaar Medical Technologies held its 13th AGM on June 30, 2026. Key outcomes include financial approval and increasing authorized share capital.
Other management change announcements
All →Apar Industries Management Change
APAR Industries re-appointed Mr. Kaushal J. Sampat as Non-Executive Independent Director for a second 5-year term from 31 January 2027. Subject to shareholder approval.
- Execution
- 60 months
The Ravalgaon Sugar Farm Management Change
Ravalgaon Sugar Farm re-appointed Sandesh Kadam & Associates as internal auditor and S. R. Padhye & Co. as secretarial auditor. It also appointed Maahi Amit Ahuja as Company Secretary and Compliance Officer effective 1 December 2026.
Tokyo Plast International Management Change
Tokyo Plast International appointed Ms. Ayushi Deepak Doshi as Company Secretary and Compliance Officer, a KMP, effective 29 October 2026. The intimation lists her credentials and states no director relationships.
Globus Power Generation Management Change
Globus Power Generation appointed Devesh Bhargava as Independent Director for five years, subject to shareholder approval. Thamattoor Prabhakaran Nair resigned as Independent Director effective 30 October 2026.
- Execution
- 5 years (29 Oct 2026 to 28 Oct 2031)
Meesho Management Change
Meesho appointed Sudhir Ganesh Sitapati as Additional Non-Executive Independent Director for 60 months, effective 28 October 2026. He is a former Godrej Consumer Products MD and CEO.
Aplab Management Change
APLAB Limited appointed Rakesh Margam as Company Secretary and Compliance Officer, effective 29 October 2026. The change is a senior management appointment with no financial impact.